Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Landos Biopharma, Inc. (LABP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.0600-0.0200 (-1.85%)
At close: 04:00PM EDT
1.0400 -0.02 (-1.89%)
After hours: 05:23PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
18,000
18,000
0
0
0
Operating Expense
61,869
56,816
30,676
13,290
7,939
Operating Income
-43,869
-38,816
-30,676
-13,290
-7,939
Net Non Operating Interest Income Expense
-
412
455
-304
-4
Other Income Expense
-11
-18
77
127
1,899
Pretax Income
-43,468
-38,422
-30,144
-13,467
-6,044
Net Income Common Stockholders
-43,468
-38,422
-30,144
-13,467
-6,044
Diluted NI Available to Com Stockholders
-43,468
-38,422
-30,144
-13,467
-6,044
Basic EPS
-
-1.02
-0.77
-0.58
-0.26
Diluted EPS
-
-1.02
-0.77
-0.58
-0.26
Basic Average Shares
-
37,558
39,163
23,103
23,103
Diluted Average Shares
-
37,558
39,163
23,103
23,103
Total Operating Income as Reported
-43,869
-38,816
-30,676
-13,290
-7,939
Total Expenses
61,869
56,816
30,676
13,290
7,939
Net Income from Continuing & Discontinued Operation
-43,468
-38,422
-30,144
-13,467
-6,044
Normalized Income
-43,433
-38,404
-30,221
-13,434
-5,938
Interest Income
-
412
455
-
-
Interest Expense
-
-
0
304
4
Net Interest Income
-
412
455
-304
-4
EBIT
-43,869
-38,816
-30,144
-13,163
-6,040
EBITDA
-43,363
-
-
-
-
Reconciled Depreciation
506
196
137
103
80
Net Income from Continuing Operation Net Minority Interest
-43,468
-38,422
-30,144
-13,467
-6,044
Total Unusual Items Excluding Goodwill
-35
-18
77
-33
-106
Total Unusual Items
-35
-18
77
-33
-106
Normalized EBITDA
-43,328
-38,602
-30,084
-13,027
-5,854
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
Advertisement
Advertisement